Oakwood Medical Investors
Search |
Home
About Us
Management Team
Physician Venture Partners
Advisory Committee
Funds
Oakwood Investors I
Oakwood Medical Investors II
Oakwood Medical Investors III
Oakwood Medical Investors IV
Oakwood Medical Investors V
News
Contact Us
Contact Information
Submit Business Plan
News
06/05/2011 - Argos Therapeutics Presents New Phase 2 Data Showing its Arcelis™ Immunotherapy AGS-003 in Combination with Sunitinib Improves Progression-Free Survival (PFS) in Patients with Advanced Renal Cell Carcinoma (RCC)
Read More
»
06/01/2011 - Argos Therapeutics´ Arcelis™ Immunotherapy for the Treatment of Renal Cell Carcinoma (RCC) in Combination with Sunitinib Demonstrates Strong Immunologic Response That Correlates to Improved Clinical Outcomes
Read More
»
06/01/2011 - LipoScience surpasses six million NMR LipoProfile tests ordered
Read More
»
05/25/2011 - Achillion Announces Initiation of Phase 1 Trial of ACH-2684 for the Treatment of Hepatitis C
Read More
»
05/23/2011 - Aptus Endosystems receives CE Mark for EndoStapling system
Read More
»
05/20/2011 - Achillion to Present at Two Upcoming Investor Conferences
Read More
»
05/18/2011 - Achillion Added to the NASDAQ Biotechnology Index (NBI)
Read More
»
05/17/2011 - EndoGastric Solutions Announces Key Patent Issued for TIF Procedure and EsophyX Technology
Read More
»
05/13/2011 - ViaCyte, Inc., Names Anthongy Gringeri Chief Development Officer
Read More
»
05/04/2011 - Achillion Reports First Quarter 2011 Financial Results
Read More
»
05/04/2011 - Argos Therapeutics´ Immunotherapy Platform Based on Recombinant Human Soluble CD83 Demonstrates Significant Promise For Solid Organ Transplantation
Read More
»
05/02/2011 - EndoGastric Solutions Names Michael Kleine as President and Chief Executive Officer
Read More
»
04/26/2011 - EndoGastric Solutions Announces American Society of General Surgeons (ASGS) Issues Position Statement Supporting Transoral Fundoplication for Select GERD Patients
Read More
»
04/20/2011 - EndoGastric Solutions Announces Transoral Fundoplication Has Expanded Presence at 2011 SAGES Annual Meeting
Read More
»
04/19/2011 - MedVantx and BCBSRI Form Partnership to Build PCMH
Read More
»
04/13/2011 - Cellular Dynamics Licenses Technology from ViaCyte
Read More
»
04/12/2011 - Lanx, Inc. Announces Launch of Concero™ Facet Screw System for Spinal Fusion
Read More
»
04/12/2011 - Lanx, Inc. Launches Durango™ Stand-Alone ALIF System
Read More
»
04/11/2011 - Lanx, Inc. Announces 17,000 Aspen™ Spinous Process Fixation Devices Implanted
Read More
»
04/08/2011 - Achillion to Present at Upcoming Investor Conferences
Read More
»
04/05/2011 - Argos Therapeutics to Present Corporate Overview and Next Steps in Clinical Development of Arcelis™ Immunotherapy at Needham & Company 10th Annual Healthcare Conference and Leerink Swann Cancer Roundtable Conference
Read More
»
03/30/2011 - Achillion Announces Positive RVR Results With ACH-1625 to Treat Chronic Hepatitis C
Read More
»
03/16/2011 - Achillion Granted U.S. Patent for ACH-1625 and Related Protease Inhibitors
Read More
»
03/11/2011 - EndoGastric Solutions Recognized in Wall Street Journal's "Next Big Thing" Top 50 Venture Capital-Funded Companies
Read More
»
03/02/2011 - Achillion Reports 2010 Fourth Quarter and Year-End Financial Results
Read More
»
02/25/2011 - EndoGastric Solutions TIF Procedure Featured on ABC's Good Morning America
Read More
»
02/17/2011 - EGS Announces Significant Expansion of U.S. Data Supporting Transoral Fundoplication
Read More
»
02/15/2011 - Lanx, Inc. Announces Launch of Epic Anterior Thoracolumbar Plating System
Read More
»
02/09/2011 - Achillion to Present at Upcoming Investor Conferences
Read More
»
Contact Us
Site Map
Privacy Policy
Site Credits
Copyright © 2007 Oakwood Medical Investors